Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
172.64B
Market cap172.64B
Price-Earnings ratio
9.43
Price-Earnings ratio9.43
Dividend yield
3.19%
Dividend yield3.19%
Average volume
17.37M
Average volume17.37M
High today
$38.87
High today$38.87
Low today
$38.41
Low today$38.41
Open price
$38.81
Open price$38.81
Volume
10.06M
Volume10.06M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Nasdaq 2h
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?

Key Points Novo Nordisk needs new products to better compete with Eli Lilly in the weight loss market. Zenagamtide is one of its promising candidates and coul...

Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?
Investing.com 4h
Viatris sues Novo Nordisk over generic Wegovy patent dispute - Investing.com

...

Viatris sues Novo Nordisk over generic Wegovy patent dispute - Investing.com
TipRanks 11h
Novo Nordisk, Nanexa enter global license agreement for injectables

Nanexa AB, a Swedish drug delivery platform company developing long-acting injectable drugs based on its proprietary PharmaShell technology platform, announces...

More NVO News

The Motley Fool 13h
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?

Today, a very valuable market -- one heading toward $100 billion by the end of the decade -- is dominated by two pharma giants, Eli Lilly and Novo Nordisk. And...

Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?
The Wall Street Journal 14h
Stocks to Watch: Akamai Technologies, Nanexa, People

↗️ People (PPLI) : Barry Diller's company has gone from potential acquirer of MGM Resorts International (MGM) to a possible target for the casino operator, The...

Stocks to Watch: Akamai Technologies, Nanexa, People
Simply Wall St 1d
Elite Dividend Stocks To Own In September 2026

Bond yields are back at two decade highs and cash finally pays a visible rate, yet many savers still watch inflation quietly erode their spending power. Reliabl...

Elite Dividend Stocks To Own In September 2026
Nasdaq 1d
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?

Key Points AbbVie maintains a diversified revenue base by expanding its presence in immunology, neuroscience, and oncology to offset patent cliffs. Novo Nordi...

AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?
TipRanks 1d
United Laboratories Wins Novo Milestone for UBT251 Diabetes and Obesity Drug

The United Laboratories International Holdings ( (HK:3933) ) has issued an update. The United Laboratories International Holdings announced that its subsidiary...

Simply Wall St 1d
Novo Nordisk Shares Dropped, So What Is Driving Attention Now?

Novo Nordisk (NYSE:NVO) has been drawing attention after recent returns turned negative across multiple time frames, including the past month and past 3 months....

Novo Nordisk Shares Dropped, So What Is Driving Attention Now?
Simply Wall St 3d
Novo Nordisk Stock Still Looks Cheap On Earnings Today

has seen its share price retreat sharply in recent years, which puts fresh focus on whether today's valuation is still supported by its earnings power. With the...

Novo Nordisk Stock Still Looks Cheap On Earnings Today

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.